P. Maccagnan et al., CONSERVATIVE MANAGEMENT OF PITUITARY APOPLEXY - A PROSPECTIVE-STUDY, The Journal of clinical endocrinology and metabolism, 80(7), 1995, pp. 2190-2197
A prospective study was conducted to evaluate the usefulness and limit
ations of conservative treatment in patients with pituitary apoplexy.
Twelve patients presenting sudden headache, visual Impair ment, or oph
thalmoplegia had the diagnosis of pituitary apoplexy established by co
mputerized tomographic scans. Initially, 11 patients received iv dexam
ethasone (2.0-16.0 mg/day). Surgery was indicated when dexamethasone f
ailed to improve visual or consciousness impairment. Among the 7 patie
nts who were treated conservatively, ophthalmoplegia recovered complet
ely in 6 and improved in 1. Follow-up computerized tomographic scans s
howed resolution of the tumor in 4 patients and residual masses in 3 p
atients who were treated conservatively. Five patients had surgery and
experienced improvement of vision and consciousness. Follow-up comput
erized tomographic scans showed residual masses in ail surgical patien
ts. Recurrences were observed in 2 patients, one in each group. The pr
evalence of pituitary deficiencies in the conservative group (9 of 17)
was similar to that of the surgical group (3 of 14), but when only pa
tients whose tumors were resolved by the apoplexy were analyzed, a sig
nificantly higher prevalence (8 of 12) was observed (P = 0.02). A retr
ospective analysis of presenting clinical and computerized tomography
data on the basis of the response to dexamethasone showed that visual
impairment did not improve during treatment with dexamethasone, wherea
s the presence of a large hypodense area within the tumor predicted co
mplete tumor resolution. These results support conservative management
of pituitary apoplexy in patients who are selected on the basis of cl
inical and tomographic findings.